This webinar, organized by NISH, aims to:
• Share with NITAGs and immunization stakeholders on the rationale and evidence underpinning vaccine switches in Africa
• Share tools and resources on vaccine switches
• Present emerging evidence from the field on specific vaccine switches: MCV (10 dose to 5 dose); Pentavalent to Hexavalent
• Discuss evidence gaps to support MCV 10 dose to 5 dose vials vaccine switches
• Identify countries interested and planning to undertake MCV 10 dose to 5 dose vials vaccine switches